Navigation Links
ZINO Society's Call for Life Sciences Entrepreneurs Seeking Funding
Date:12/8/2008

SEATTLE, Dec. 8 /PRNewswire/ -- ZINO Society is pleased to present ZINO Life: Life Sciences Investment Forum in partnership with the Washington Biotechnology and Biomedical Association (WBBA), on February 24, 2009.

ZINO Life will include exhibition space, networking, company presentations, keynote speaker Bruce Montgomery (Gilead Sciences), and an expert panel including H. Stewart Parker (formerly Targeted Genetics), Wayne Embree (Reference Capital Management LLC), Alan Smith (Fenwick & West LLP) and others. The day culminates with a wine reception and People's Choice Awards for presenters. In addition, one of the 12 companies will be invited to present at WBBA's Invest Northwest conference, March 17th - 18th 2009.

Reference Capital will select the best investment opportunity as determined by Reference Capital Management LLC and a $50,000 fund will be awarded in early 2009. "We see excellent opportunities within the Life Sciences in the region and we want to capitalize on them," said Founder and Managing Director of Reference Capital, Wayne Embree.

Selection Process:

Twelve early stage or expansion companies in the areas of life sciences, biotechnology, medical devices, diagnostics, and health-care information technology looking for start up or expansion capital. Companies will be selected to present their business plans to angel investors and business leaders.

Companies who would like to be considered to present at ZINO Life need to submit an online application, upload an executive summary that is no more than 5 pages long, and pay a $150 application fee.

The ZINO Society screening board will select a group of semi-finalists to move forward to a second level screening round. Those companies will be asked to present to the ZINO Society screening/coaching board on January 22 or 23, 2009. From these finalists, 12 companies will be selected to present their businesses at ZINO Life on February 24, 2009. The companies selected to present will participate in two coaching sessions prior to the forum, included in the presentation fee. The goal of the coaching sessions is to help each presenter be as effective as possible during his/her presentation to the investors.



    Facts Sheet:

    Application deadline:              January 13, 2009, by 5:00 PM
    Application site:                 http://tinyurl.com/5hyxam
    Application fee:                   $150 first-time applicants, $100
                                        returning applicants
    Presentation format:               5 minutes presentation 2 minutes for
                                        Q & A.
    Presentation fee:                  $850
    Semi-finalists notified:           January 20, 2009
    Semi-finalists present to
     ZINO Life screening committee:    January 22 or 23, 2009 (Please reserve
                                        these dates)
    Presenters announced:              January 26, 2009
    Coaching meetings:                 February 2 - February 20, 2009
    ZINO Life: Life Sciences
     Investment Forum                  February 24, 2009 2:00 PM - 6:00 PM


About ZINO Society

ZINO Society is a premier membership, business and social network that connects accredited investors with entrepreneurs seeking funding. Since its conception, ZINO Society has helped facilitate in excess of $9.1 million for early-stage and expansion businesses.

About The Washington Biotechnology & Biomedical Association (WBBA)

The Washington Biotechnology & Biomedical Association is a not-for-profit association of more than 450 life sciences companies, universities, academic institutions and others working together to provide better health to people everywhere.


'/>"/>
SOURCE ZINO Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
2. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
4. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
5. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
6. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
7. Cardiac Science to Present at the UBS Global Life Sciences Conference
8. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
9. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. Clarient to Present at the UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... TN (PRWEB) , ... February 17, 2017 , ... ... Inc. (ISTS) brings its educational assistance management solution to the exhibit floor for ... Center in Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 ...
(Date:2/17/2017)... Verdes, CA (PRWEB) , ... February 17, 2017 ... ... emotional flow is Dr. Carol Francis' goals for each and every ... Conference, Dr. Carol Francis will demonstrate five different brainwave tools which help energize ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of the ... 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs ... across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will serve ... Health and the U.S. Soccer Foundation announced today that they have awarded nine ... for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of soccer ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... clinical operations executives and focusing on all facets of clinical trial planning and ... management , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: